Sign inJoin waitlistJoin the waitlist

Katie Albert

Director · University of Washington School of Medicine

Credentials: · · · ·

History

University of Washington School of Medicine
Present

Hematology and Medical Oncology
2011–2014
Internal Medicine
2008–2011
George Washington Univ Sch of Med
2004–2008

Research

Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials
The Lancet Oncology · 2020 · 835 citations
Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
The Lancet Oncology · 2018 · 458 citations
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
Nature Medicine · 2021 · 285 citations

Erin Rudzinski
8 papers
Julie Park
8 papers
Navin Pinto
8 papers
Nicholas Vitanza
7 papers
Rebecca Gardner
7 papers
Steven DuBois
7 papers
Douglas Hawkins
6 papers
Jessica Davis
6 papers
Theodore Laetsch
6 papers
David Loeb
5 papers
Erin Crotty
5 papers · 1 as a fellow
Jason Wright
5 papers

Clinical trials

A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma
Principal investigator · Active not recruiting · Phase 1
Seattle Children's Hospital
2022–2040
B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
Principal investigator · Active not recruiting · Phase 1
Seattle Children's Hospital
2020–2040
Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01
Study chair · Active not recruiting · Phase 1
Seattle Children's Hospital
2014–2038
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2020–2027